South Korea's LG AI Research said Wednesday that it has agreed to cooperate with D&D Pharmatech to develop next-generation ...

The companies aim to create a tablet-form treatment to improve the safety and absorption rates of peptide drugs.

LG AI Research announced today that it has signed a master agreement for a joint next-generation oral peptide drug development project with D&D Pharmatech at the LG Twin Towers in Yeouido, Seoul.

Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by ...

On June 25, independent research firm Growth Research evaluated D&D Pharmatech, stating that the company is increasing the possibility of global techn ...

BARCELONA, Spain & HAYWARD, Calif.--(BUSINESS WIRE)--This week at CPHI Barcelona, Pharmatech Associates will showcase its expertise and capabilities that help global pharmaceutical and emerging ...

HAYWARD, Calif.-- Pharmatech Associates, a compliance consulting firm serving companies in the pharmaceutical, biotech and medical device industries, was selected by Innovent Biologics to provide ...

DUBLIN, IRELAND and FORT WORTH, TEXAS – February 13, 2014 – Actavis plc (NYSE: ACT) and TPG, the global private investment firm, today announced that they have entered into definitive agreements, ...

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Garry Pairaudeau, Chief Technology Officer at Exscientia*, about pharmatech, AI, and more. My name is Garry Pairaudeau, ...